Wolverine Trading
AUPH icon

Wolverine Trading’s Aurinia Pharmaceuticals AUPH Stock Holding History

Wolverine Trading’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,000
Closed -$225K – 5619
2025
Q2 		$225K Buy
26,000
+1,100
+4% +$8.82K ﹤0.01% 3787
2025
Q1 		$206K Sell
24,900
-5,000
-17% -$40.5K ﹤0.01% 3928
2024
Q4 		$274K Sell
29,900
-1,800
-6% -$14.7K ﹤0.01% 4126
2024
Q3 		$231K Buy
+31,700
New +$197K ﹤0.01% 3919
2024
Q2 		– Sell
-21,800
Closed -$109K – 4458
2024
Q1 		$109K Sell
21,800
-47,500
-69% -$322K ﹤0.01% 4030
2023
Q4 		$623K Buy
+69,300
New +$571K ﹤0.01% 2731
2023
Q3 		– Sell
-116,400
Closed -$1.07M – 4480
2023
Q2 		$1.07M Buy
116,400
+38,500
+49% +$400K ﹤0.01% 1962
2023
Q1 		$855K Buy
77,900
+63,200
+430% +$557K ﹤0.01% 2038
2022
Q4 		$64K Buy
+14,700
New +$85.3K ﹤0.01% 3527
2022
Q2 		– Sell
-108,100
Closed -$1.34M – 4473
2022
Q1 		$1.34M Buy
108,100
+20,300
+23% +$314K ﹤0.01% 2144
2021
Q4 		$2M Sell
87,800
-23,200
-21% -$550K ﹤0.01% 1891
2021
Q3 		$2.55M Buy
+111,000
New +$1.76M ﹤0.01% 1888

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's AUPH Position: Q2 2025 in Review

Wolverine Trading sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 19,374 shares — an estimated $155K sold.

Wolverine Trading first reported a position in AUPH in Q3 2021 and held it in 6 quarters. The position peaked at $1.5M in Q3 2024. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • Wolverine Trading reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 19,374 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $155K.
  • Wolverine Trading first reported a position in Aurinia Pharmaceuticals in Q3 2021 and held it in 6 quarters.
  • Wolverine Trading's Aurinia Pharmaceuticals position peaked at $1.5M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.